Clinical Trials Logo

Clinical Trial Summary

Pediatric obstructive sleep apnea (OSA) can lead to severe health issues if untreated. While polysomnography is the gold standard for diagnosis, current surgical treatment in Denmark relies on caregiver reports and clinical exams. Approximately 25% of patients have persistent symptoms post-surgery, indicating the need for better diagnostic and treatment options. Drug-Induced Sleep Endoscopy (DISE) allows dynamic upper airway visualization during mild sedation, aiding in treatment decisions. This research project aims to evaluate the impact of DISE-guided interventions on pediatric OSA outcomes and compare its effectiveness and cost/benefit with traditional diagnostic approaches.


Clinical Trial Description

Background 1.1 Pediatric Obstructive Sleep Apnea Pediatric OSA ranges from simple snoring to severe upper airway obstruction during sleep. Left untreated, it can lead to significant health issues, especially in children, impacting their cognitive development, learning, and social interactions. 1.2 Diagnostics and Surgical Strategies Polysomnography (PSG) is the gold standard for diagnosing OSA. In Denmark, PSG isn't widely used due to equipment and setup constraints. Surgical treatment for pediatric OSA in Denmark relies primarily on clinical examination of the tonsils and parental reports of symptoms. 1.3 Drug-Induced Sleep Endoscopy (DISE) DISE is a method for visualizing upper airway collapse during sleep using a flexible endoscope. It is increasingly used to guide surgical decisions for pediatric OSA in various countries, though its clinical impact remains uncertain. 2. Aims This research project aims to evaluate the impact of DISE-guided surgical interventions on pediatric OSA outcomes and compare the effectiveness of a DISE-inclusive diagnostic approach with the traditional pediatric OSA workup. The specific objectives are: Evaluate treatment outcomes, including the reduction in persistent OSA post-surgery. Classify and compare patterns of airway obstruction observed during DISE in surgically naive children. Compare diagnostic approaches in terms of cost, time, and benefits. Identify adverse events and complications related to sedation and surgery. Assess the feasibility of DISE in Danish patients through a pilot study. 3. Methods 3.1 Randomized Controlled Trial (RCT) Patients undergo initial clinical examination and home respiratory polygraphy (HRP). Based on AAO-HNSF criteria, patients with OSA will undergo DISE. The sample size for the RCT is 250 patients, with 125 in each group. 3.2 Statistics Statistical analysis will involve Chi-square tests, logistic regression, and T-tests for comparisons between groups. 3.3 Sedation Protocol Sedation will use propofol to induce a state similar to natural sleep, guided by preoperative polysomnography. 3.4 Assessment of Obstruction Obstruction characteristics will be documented using the International Pediatric Sleep Endoscopy Scale (IPSES). 3.5 Follow-up Patients will have two follow-up appointments at three and 12 months postoperatively, including clinical examination, HRP, and re-DISE at three months for both groups. 4. Outcomes 4.1 Primary Outcome The primary outcome is the treatment failure rate, comparing the proportion of patients with persistent OSA post-surgery in the DISE-guided surgery group to the non-DISE-guided surgery group. 4.2 Secondary Outcomes Secondary outcomes include evaluation of DISE findings, changes in apnea-hypopnea index (AHI), quality of life improvement, DISE-score/airway obstruction pattern, and identification of adverse events and complications. 4.3 Confounding Factors Population characteristics, such as age, obesity (BMI), and gender, will be considered. 5. Ethical Considerations In cases where no obstruction is identified related to tonsils or adenoids, alternative treatment options will be discussed with parents. Privacy and informed consent are required. The study will follow ethical and data protection regulations ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06093802
Study type Interventional
Source Regional Hospital West Jutland
Contact Mascha Hildebrandt, MD
Phone +4541289051
Email mascha.hilde@gmail.com
Status Not yet recruiting
Phase N/A
Start date January 1, 2025
Completion date July 1, 2029

See also
  Status Clinical Trial Phase
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Active, not recruiting NCT05154214 - Surgical Treatment of Children With OSA and Small Tonsils or Down Syndrome
Recruiting NCT06367400 - Validation of Pediatric Sleep Questionnaire on a Swedish Cohort
Enrolling by invitation NCT05908110 - Evidence-based Pediatric Obstructive Sleep Apnea Detection N/A
Completed NCT03134300 - Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population N/A
Recruiting NCT05115968 - Single Cell Sequencing of Tonsillar Tissue in Children With OSA
Recruiting NCT03370731 - Surgical Versus Nonsurgical Treatment on Quality of Life for Children With Controversial OSA Diagnoses N/A
Completed NCT02247167 - Endothelial Dysfunction and Oxidative Stress in Children With Sleep Disordered Breathing. Phase 1/Phase 2
Completed NCT05499455 - SleepPOSAtive Trial N/A
Active, not recruiting NCT05382494 - Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children Phase 4
Recruiting NCT03995628 - Steroids and Pain Control After Tonsillectomy Phase 2
Recruiting NCT04732572 - Brain Tissue Integrity and Autonomic Function Alterations in Childhood OSA and ADHD, and After Adenotonsillectomy. N/A
Active, not recruiting NCT04349397 - Use of Analgesics and Pain Scores After Pediatric Adenotonsillectomy
Completed NCT04328402 - Factors Correlated With Obstructive Sleep Apnea in Children and Adolescents